Clinical characteristics of patients in the fluticasone and placebo groups at baseline
| Fluticasone(n = 43, 23F) | Placebo(n = 43, 34F) | |
|---|---|---|
| Data shown are mean (SD). | ||
| *No significant difference between fluticasone and placebo groups (p>0.05). | ||
| Age (years) | 57.7 (14.4) | 59.2 (14.2) |
| Age at onset of symptoms (years) | 41.8 (18.8) | 40.8 (18.5) |
| Smoking history | ||
| Never | 33 | 36 |
| Ex | 8 | 7 |
| Current | 2 | 0 |
| Past medical history | ||
| Nil else | 26 | 25 |
| Hypertension | 5 | 4 |
| Hypothyroidism | 0 | 2 |
| Pulmonary TB | 3 | 0 |
| Ischaemic heart disease | 2 | 4 |
| Peptic ulcer disease | 2 | 2 |
| Others | 8 | 7 |
| Current medications | ||
| None | 17 | 11 |
| Inhaled bronchodilators | 11 | 19 |
| Antihypertensives | 5 | 5 |
| Theophylline or oral β2 agonist | 7 | 7 |
| Others | 12 | 8 |
| Sputum pathogen | ||
| Commensals | 25 | 27 |
| P aeruginosa | 12 | 11 |
| H influenzae | 6 | 5 |
| No. of bronchiectatic lung segments | 3.0 (1.6) | 2.8 (1.6) |